Page last updated: 2024-09-05

sorafenib and menaquinone 6

sorafenib has been researched along with menaquinone 6 in 1 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (menaquinone 6)	Trials (menaquinone 6)	Recent Studies (post-2010) (menaquinone 6)
6,520	730	5,251	3,600	123	2,844

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fang, D; Gao, J; Liu, J; Rao, Z; Zhang, A; Zhang, B; Zhang, Y; Zhao, J; Zhao, Y	1

Other Studies

1 other study(ies) available for sorafenib and menaquinone 6

Article	Year
Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells. Clinics (Sao Paulo, Brazil), 2012, Volume: 67, Issue:9 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Flow Cytometry; Liver Neoplasms; Mice; Mice, Nude; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Sorafenib; Time Factors; Treatment Outcome; Vitamin K 2	2012

Article

Year

Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells.

Clinics (Sao Paulo, Brazil), 2012, Volume: 67, Issue:9

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Flow Cytometry; Liver Neoplasms; Mice; Mice, Nude; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Sorafenib; Time Factors; Treatment Outcome; Vitamin K 2

2012